Seasoned investor and operator focused on private equity and real estate capital strategies. DONNALEE GUERIN is a senior executive with experience sourcing deals, structuring transactions and managing portfolio companies across asset-heavy sectors. Known for blending operational oversight with capital markets discipline, she has advised on growth financings, restructurings and exits. Market-facing skills include investor relations, due diligence and cross-border transaction execution.
Seasoned investor and operator focused on private equity and real estate capital strategies. DONNALEE GUERIN is a senior executive with experience sourcing deals, structuring transactions and managing portfolio companies across asset-heavy sectors. Known for blending operational oversight with capital markets discipline, she has advised on growth financings, restructurings and exits. Market-facing skills include investor relations, due diligence and cross-border transaction execution.
Combines operationally driven private equity and real estate investing with disciplined capital-structure engineering to unlock value in asset-heavy sectors. Prioritizes control or influential minority positions where hands-on governance, operational turnaround, and growth-capital deployment accelerate cash flow improvement and multiple expansion. Underwrites deals with scenario-based downside protection, liquidity pathway planning and staged financing. Time horizon is medium-to-long term with active portfolio management, regular KPI-driven interventions, and exit preparation via strategic sale, refinancing or public-market pathways. Cross-border execution and investor-relations discipline support complex transactions.
Combines operationally driven private equity and real estate investing with disciplined capital-structure engineering to unlock value in asset-heavy sectors. Prioritizes control or influential minority positions where hands-on governance, operational turnaround, and growth-capital deployment accelerate cash flow improvement and multiple expansion. Underwrites deals with scenario-based downside protection, liquidity pathway planning and staged financing. Time horizon is medium-to-long term with active portfolio management, regular KPI-driven interventions, and exit preparation via strategic sale, refinancing or public-market pathways. Cross-border execution and investor-relations discipline support complex transactions.
| Trades 2021 | Longs Won 1307/2021 64% | Profit Factor 30.16 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $3.96M |
| Average Win $448,182.52 | Best Trade (Aug 17) $127.5M | Sharpe Ratio -13.44 |
| Average Loss -$27,204.55 | Worst Trade (Dec 31) -$4.62M | Z-Score 4.04 (100%) |
| Commissions $0 | Avg. Trade Length 1y 2m 1w 5d | Expectancy $280,232.81 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.11% |
| Consecutive Losing Trades | 66,667 | 60,000 | 53,333 | 46,667 | 40,000 | 33,333 | 26,667 | 20,000 | 13,333 | 6,667 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
A Agilent Technologies Inc. | 1,320 | $183,831 | $196,310.4 | - | $12,479.4 | 6.79% | 0.0 |
AAPL Apple Inc. | 93,009 | $19M | $28.36M | - | $9.36M | 49.26% | -1.087% |
ABBV AbbVie Inc. | 3,815 | $686,382.07 | $946,005.55 | - | $259,623.48 | 37.82% | 0.0 |
ABT Abbott Laboratories | 5,698 | $687,087.94 | $625,184.56 | - | -$61,903.38 | -9.01% | +1.013% |
ACN Accenture plc Class A | 276 | $79,415.7 | $49,630.32 | - | -$29,785.38 | -37.51% | +0.881% |
ADI Analog Devices, Inc. | 997 | $219,352.47 | $382,773.22 | - | $163,420.75 | 74.5% | -0.001% |
ADP Automatic Data Processing Inc. | 3,120 | $781,631.43 | $853,866 | - | $72,234.57 | 9.24% | -0.002% |
AEE Ameren Corporation | 487 | $37,440.31 | $52,109 | - | $14,668.69 | 39.18% | 0.0 |
AEP American Electric Power Company, Inc. | 25 | $2,837.88 | $3,071 | - | $233.12 | 8.21% | 0.0 |
ALB Albemarle Corporation | 7 | $993 | $905.52 | - | -$87.48 | -8.81% | -1.41% |
AMAT Applied Materials, Inc. | 320 | $65,315.29 | $167,078.4 | - | $101,763.11 | 155.8% | 0.0 |
AMD Advanced Micro Devices, Inc. | 189 | $30,754.49 | $88,746.84 | - | $57,992.35 | 188.57% | 0.0 |
AMGN Amgen Inc. | 420 | $121,444.52 | $175,224 | - | $53,779.48 | 44.28% | 0.0 |
AMP Ameriprise Financial, Inc. | 19 | $9,316 | $10,593.07 | - | $1,277.07 | 13.71% | 0.0 |
AMZN Amazon.com Inc | 234,823 | $36.21M | $63.94M | - | $27.73M | 76.57% | -2.093% |
APH Amphenol Corporation | 980,368 | $24.98M | $82.2M | - | $57.22M | 229.03% | 0.0 |
APO Apollo Global Management, Inc. | 36 | $5,211 | $4,752.72 | - | -$458.28 | -8.79% | 0.0 |
ARKK ARK Innovation ETF Fund | 244 | $12,778 | $19,627.36 | - | $6,849.36 | 53.6% | 0.0 |
ASML ASML Holding N.V. New York Registry Shares | 68 | $56,660.77 | $122,357.84 | - | $65,697.07 | 115.95% | +3.802% |
ATAI AtaiBeckley Inc. | 2,045 | $8,384.5 | $14,826.25 | - | $6,441.75 | 76.83% | 0.0 |